Christian Weber

Immunology · Nature Medicine · 2002–2016

A researcher in the Science corpus: 12 papers; trusts 5 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 95 citations into it; #1,081 of 2,160 by trust here, #602 by citations
• Molecular Biology — 62 citations into it
• Epidemiology — 17 citations into it
• Endocrinology, Diabetes and Metabolism — 8 citations into it

Whom Christian Weber trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. I. Tabas
2. G. Hansson
3. Peter Libby
4. A. Zernecke
5. S. Nissen
6. V. Papayannopoulos
7. F. Geissmann
8. K. Wolski
9. Oliver Soehnlein
10. K. Shortman

Who trusts Christian Weber overall

1. Peter Libby
2. A. Lichtman
3. Guolan Lu
4. C. Shi
5. K. Woollard

Papers from Christian Weber's perspective

Ordered by how strongly the researchers Christian Weber trusts endorse each paper. Same corpus, a different order for every researcher.

1. The immune response in atherosclerosis: a double-edged sword (Nature reviews. Immunology)
2. Cytokines in atherosclerosis: pathogenic and regulatory pathways. (Physiological Reviews)
3. Blood monocytes consist of two principal subsets with distinct migratory properties. (Immunity)
4. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. (Journal of Clinical Investigation)
5. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
6. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models (Nature reviews. Immunology)
7. The many roles of chemokines and chemokine receptors in inflammation. (New England Journal of Medicine)
8. Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency (Arteriosclerosis, Thrombosis and Vascular Biology)
9. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment (Nature Medicine)
10. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. (The Lancet)

Their papers

• MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 (2014) — 624 citations
• Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection (2009) — 1,364 citations
• Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange (2010) — 811 citations
• Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype (2016) — 714 citations
• Rhythmic modulation of the hematopoietic niche through neutrophil clearance (2013) — 681 citations
• Atherosclerosis: current pathogenesis and therapeutic options (2011) — 2,166 citations
• Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis (2010) — 703 citations
• Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis (2009) — 797 citations
• The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models (2008) — 840 citations
• MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment (2007) — 1,285 citations
• Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E (2003) — 1,109 citations
• JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes (2002) — 716 citations